Publications by authors named "Morris Groves"

Claim this Profile
A
Author Correction: Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.
Farshad Nassiri, Vikas Patil, Leeor S Yefet, Olivia Singh, Jeff Liu, Morris D Groves

Nat Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.
Farshad Nassiri, Vikas Patil, Leeor S Yefet, Olivia Singh, Jeff Liu, Morris D Groves

Nat Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokinetics.
Priya U Kumthekar, Michael J Avram, Andrew B Lassman, Nancy U Lin, Eudocia Lee, Morris D Groves

Neuro Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study.
Andrew B Lassman, Juan Manuel Sepúlveda-Sánchez, Timothy F Cloughesy, Miguel J Gil-Gil, Vinay K Puduvalli, Morris D Groves

Clin Cancer Res· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bintrafusp alfa (M7824), a bifunctional fusion protein targeting TGF-β and PD-L1: results from a phase I expansion cohort in patients with recurrent glioblastoma.
Mustafa Khasraw, Michael Weller, David Lorente, Kathryn Kolibaba, Chee Khoon Lee, Morris Groves

Neurooncol Adv· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma.
Vinay K Puduvalli, Jing Wu, Ying Yuan, Terri S Armstrong, Elizabeth Vera, Morris D Groves

Neuro Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer.
Rachna Malani, Martin Fleisher, Priya Kumthekar, Xuling Lin, Antonio Omuro, Morris D Groves

J Neurooncol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differentiation of 2-hydroxyglutarate enantiomers and its lactones by gas chromatography/electron ionization tandem mass spectrometry.
Shinji K Strain, Morris D Groves, Mark R Emmett

Rapid Commun Mass Spectrom· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications.
Adrienne Boire, Dieta Brandsma, Priscilla K Brastianos, Emilie Le Rhun, Manmeet Ahluwalia, Morris D Groves

Neuro Oncol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to Unexpectedly low rates of neuropsychiatric adverse effects associated with mefloquine repurposed for the treatment of glioblastoma.
Stefania Maraka, Morris D Groves, Marta Penas-Prado

Cancer· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma.
Stefania Maraka, Morris D Groves, Aaron G Mammoser, Isaac Melguizo-Gavilanes, Charles A Conrad

Cancer· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Most common sites on MRI of intracranial neoplastic leptomeningeal disease.
J Matthew Debnam, Rory R Mayer, T Linda Chi, Leena Ketonen, Jeffrey S Weinberg, Morris D Groves

J Clin Neurosci· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leptomeningeal metastases presenting exclusively with ocular disturbance in 34 patients: A tertiary care cancer hospital experience.
Rory Richard Mayer, Benjamin Jay Frankfort, Ben A Strickland, James Matthew Debnam, Ian E McCutcheon, Morris D Groves

J Clin Neurosci· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leptomeningeal metastases: a RANO proposal for response criteria.
Marc Chamberlain, Larry Junck, Dieta Brandsma, Riccardo Soffietti, Roberta Rudà, Morris D Groves

Neuro Oncol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between F-FDG PET/CT and MRI appearance of spinal leptomeningeal disease before and after treatment at a tertiary referral center.
Harry Papasozomenos, Nandita Guha-Thakurta, Rory R Mayer, Jeffrey S Weinberg, Morris D Groves

J Solid Tumors· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study.
James Schuster, Rose K Lai, Lawrence D Recht, David A Reardon, Nina A Paleologos, Morris D Groves

Neuro Oncol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II adjuvant factorial study of dose-dense temozolomide alone and in combination with isotretinoin, celecoxib, and/or thalidomide for glioblastoma.
Marta Penas-Prado, Kenneth R Hess, Michael J Fisch, Lore W Lagrone, Morris D Groves

Neuro Oncol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials.
Marc Chamberlain, Riccardo Soffietti, Jeffrey Raizer, Roberta Rudà, Dieta Brandsma, Morris D Groves

Neuro Oncol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I/II study of erlotinib and temsirolimus for patients with recurrent malignant gliomas: North American Brain Tumor Consortium trial 04-02.
Patrick Y Wen, Susan M Chang, Kathleen R Lamborn, John G Kuhn, Andrew D Norden, Morris D Groves

Neuro Oncol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab use in disseminated choroid plexus papilloma.
Mark Daniel Anderson, Brett J Theeler, Marta Penas-Prado, Morris D Groves, W K Alfred Yung

J Neurooncol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1/1b study of lonafarnib and temozolomide in patients with recurrent or temozolomide refractory glioblastoma.
Shlomit Yust-Katz, Diane Liu, Ying Yuan, Vivien Liu, Sanghee Kang, Morris Groves

Cancer· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The identification and characterization of breast cancer CTCs competent for brain metastasis.
Lixin Zhang, Lon D Ridgway, Michael D Wetzel, Jason Ngo, Wei Yin, Morris D Groves

Sci Transl Med· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leptomeningeal metastases from genitourinary cancer: the University of Texas MD Anderson Cancer Center experience.
Shlomit Yust-Katz, Samuel Mathis, Morris D Groves

Med Oncol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I study of GRN1005 in recurrent malignant glioma.
Jan Drappatz, Andrew Brenner, Eric T Wong, April Eichler, David Schiff, Morris D Groves

Clin Cancer Res· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I/II trial of pazopanib in combination with lapatinib in adult patients with relapsed malignant glioma.
David A Reardon, Morris D Groves, Patrick Y Wen, Louis Nabors, Tom Mikkelsen

Clin Cancer Res· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis